Researchers identify the strategy that highly aggressive brain tumor cells use to fuel their relentless expansion and reveal a fresh target for cancer therapy.

In this preliminary analysis, the study treatment neither built up in organs and nor destroyed the bone marrow’s ability to make blood cells.

The Regional Oncology Active Research (ROAR) initiative of the Southeast Cancer Foundation supports radiation oncology research.

Published in Faculty Excellence

Awards were given in four key areas — clinical care, medical education, laboratory research and patient-oriented research projects.

Published in Faculty Excellence

Bonner is chairman of the Department of Radiation Oncology.

Published in Faculty Excellence

A combination of cancer drugs showed promise in killing triple-negative breast cancer cells.

Eddy S. Yang, M.D., Ph.D., was named the inaugural holder of the ROAR Southeast Cancer Foundation Endowed Professorship
Published in Faculty Excellence

Discovery may broaden clinical applications for a class of drugs that show promise for the treatment of familial breast and ovarian cancer.

UAB researchers say the MARCKS protein may be a biomarker for brain tumors and hold potential for targeted therapy.

UAB cancer researcher will use grant to study breast cancer cells.

Published in Faculty Excellence
UAB Medicine — The Cancer Center at RMC will expand oncology services in the Lake Martin, Ala., area.
Published in Focus on Patient Care

Gene's link to brain tumors among top clinical research advances of 2011.

Laboratory evidence offers new insight in blocking cancer cell growth with electromagnetic fields.

A multi-department team of UAB brain tumor researchers has received a grant to take a systems-biology approach to treatment.

Physicians first to use new imaging technology tool to increase accuracy in inoperable lung cancer case.
Published in Focus on Patient Care

A UAB researcher has found a potential new way to treat head and neck cancer.

Back to Top